Drug
Leo 90100 Aerosol Foam
Leo 90100 Aerosol Foam: highest development phase Phase 3, developed by LEO Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO 90100 Aerosol Foam NCT02310646 | Phase 3 | Psoriasis Vulgaris |
| LEO 90100 aerosol foam NCT02973776 | Phase 1 | Psoriasis Vulgaris |
Latest
No recent events.
Follow Leo 90100 Aerosol Foam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.